Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC092143.1 ENSG00000198211 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 19.0" "CAB011512, HPA043640, HPA046280" Uncertain Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.4 0.2 0.2 0.1 0.8 0.3 0.1 0.4 0.7 1.0 0.5 0.6 0.0 0.1 1.2 0.9 1.0 0.7 1.5 1.8 0.2 0.4 0.1 1.3 0.4 0.1 0.9 0.4 4.0 0.2 0.1 0.7 1.4 2.0 2.6 0.1 0.3 0.1 0.1 0.6 5.1 0.4 0.5 2.8 0.6 0.1 10.9 0.2 0.0 0.3 0.0 0.1 1.0 5.1 0.1 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.3 0.2 0.8 0.4 0.7 0.2 0.4 0.9 0.4 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Approved Supported "Golgi apparatus,Vesicles,Mitotic spindle" Yes No "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: AB_2686710" "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 15.0 16.7 10.3 20.7 14.4 18.4 16.1 21.9 13.7 16.2 13.0 15.3 15.6 8.7 17.2 13.9 13.2 13.1 11.7 11.4 9.8 7.3 14.1 14.8 12.5 16.1 13.9 11.8 23.6 24.8 32.5 17.4 14.1 14.8 11.3 13.6 11.5 14.7 17.1 20.9 14.9 16.0 12.5 13.3 16.1 13.9 13.0 14.4 23.1 21.5 9.2 17.2 16.2 12.0 3.8 2.8 10.6 2.4 2.3 3.4 0.7 15.3 12.8 11.9 5.1 9.4 13.4 7.2 6.8 9.6 8.4 8.0 8.8 3.6 16.4 5.4 12.7 9.6 7.1 16.7 10.1 10.4 13.2 7.6 22.3 8.1 7.3 5.2 20.6 7.9 8.9 4.9 13.1 11.7 6.8 12.4 3.7 18.1 7.1 7.7 5.9 10.3 4.8 8.0 5.8 7.6 10.5 19.3 5.6 6.1 15.8 8.9 13.6 13.4 7.0 6.2 9.5 4.6 7.4 19.4 8.8 9.9 5.9 10.4 9.5 13.3 22.0 6.4 10.2 5.7 10.6 1.6 0.9 2.7 1.2 3.4 1.7 2.1 2.3 1.3 3.8 2.3 2.6 2.7 2.3 2.4 2.8 1.6 0.7 10.3 14.4 21.9 13.7 9.8 7.3 13.9 11.8 14.8 14.4 29.8 26.2 37.9 25.6 40.9 59.4 42.2 30.6 10.7 35.2 34.9 180.6 28.6 1.7 22.3 35.8 45.7 44.5 0.0 26.8 18.3 30.5 38.3 29.9 44.3 26.3 65.2 31.2 46.1 58.6 13.7 42.0 32.8 21.9 31.5 36.3 39.9 28.2 25.9 55.5 19.2 89.9 38.8 42.4 52.0 44.5 47.9 31.8 56.8 37.0 38.9 C1orf123 FLJ20580 ENSG00000162384 "Chromosome 1 open reading frame 123" Q9NWV4 1 53214099-53220617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" Yes No 380000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 32.6 21.4 27.8 19.1 29.4 12.9 26.3 16.4 25.4 29.2 33.2 25.0 22.7 15.4 34.0 28.9 25.7 32.2 22.7 28.8 24.3 22.3 26.9 29.3 20.3 18.3 24.7 26.3 33.5 17.5 21.0 20.1 22.5 23.7 31.7 24.7 24.0 16.6 33.5 44.4 14.3 16.9 48.4 22.5 18.4 23.4 26.0 23.8 18.9 26.0 18.0 19.4 28.9 26.0 25.5 38.4 31.5 39.1 30.5 36.5 26.4 11.7 12.8 16.9 15.4 39.3 50.5 15.0 17.7 18.9 18.0 19.5 10.9 10.2 18.3 14.9 21.4 17.5 4.7 10.4 17.4 21.9 23.5 17.7 18.6 9.9 16.3 38.8 21.4 12.3 32.7 19.0 19.2 20.4 27.3 29.3 22.7 19.2 5.1 22.5 19.8 26.2 20.1 28.2 14.5 20.4 19.2 21.5 14.4 20.8 12.0 14.3 13.8 16.7 15.4 16.7 28.7 11.0 21.9 18.3 20.9 12.3 14.4 17.2 7.5 10.8 20.6 16.8 21.4 16.0 28.3 32.1 31.5 30.4 39.1 27.7 25.5 30.2 31.7 38.4 23.6 33.7 33.4 13.0 30.5 31.8 25.9 36.5 26.4 27.8 29.4 16.4 25.4 24.3 22.3 24.7 26.3 23.7 23.8 11.9 22.3 30.6 23.2 14.7 32.1 41.2 20.4 42.8 25.0 36.6 2.0 51.1 86.2 35.5 86.3 45.6 23.9 0.0 31.5 63.6 57.4 21.8 30.1 40.4 58.2 17.5 27.0 35.6 28.2 159.2 74.5 32.0 33.7 43.3 31.3 44.6 30.1 36.6 92.6 79.1 28.3 64.7 60.5 49.3 36.1 13.7 39.0 20.8 32.6 18.0 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500893-91525764 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: AB_2674807" "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 2.5 3.7 5.7 7.6 8.9 15.4 4.3 19.4 10.3 2.5 4.2 1.4 0.9 4.2 2.8 2.6 4.7 1.7 2.6 1.9 6.8 5.2 3.6 2.3 5.1 11.7 4.0 4.7 3.7 2.4 2.2 12.3 7.9 5.2 2.7 6.8 2.3 2.5 2.3 1.0 6.8 4.9 3.3 5.9 15.1 2.6 21.2 4.7 18.7 2.5 4.5 12.0 4.2 3.0 1.6 3.5 0.1 1.6 2.4 6.5 2.1 14.2 4.2 27.6 7.8 0.6 3.7 8.8 5.4 4.3 10.7 11.7 8.9 5.1 9.9 7.6 3.4 9.3 6.2 18.1 6.1 14.8 16.4 15.5 15.0 12.2 4.1 1.0 16.3 5.5 1.9 1.8 9.8 5.6 1.9 4.1 13.9 19.8 14.5 7.3 5.2 14.0 14.6 22.9 7.8 10.1 17.3 22.9 6.3 4.6 10.7 21.9 8.6 17.1 4.7 9.6 7.1 4.4 8.0 3.4 12.1 10.7 9.4 8.1 5.3 6.7 26.5 4.3 15.9 4.4 0.0 1.6 0.0 5.9 1.2 5.2 1.5 4.5 5.6 3.5 1.6 2.5 5.1 0.1 2.4 0.3 2.1 6.5 2.1 5.7 8.9 19.4 10.3 6.8 5.2 4.0 4.7 5.2 4.7 0.0 0.6 2.2 1.1 5.3 7.6 1.3 0.0 1.4 1.2 1.8 0.0 5.3 3.3 1.1 28.3 2.8 0.2 0.0 2.2 5.1 4.6 0.7 4.6 0.0 2.2 3.2 0.0 3.1 1.8 12.9 0.9 1.0 3.3 1.0 1.3 1.3 1.0 1.1 0.7 0.1 4.7 6.5 3.1 28.4 20.6 3.1 1.8 5.1 2.9 0.9 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CRYBB3 CRYB3 ENSG00000100053 "Crystallin beta B3" P26998 22 25199850-25207363 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "granulocytes: 4.6;Muller glia cells: 3.5;Proximal tubular cells: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;HEK 293: 3.7;HeLa: 4.5;hTERT-HME1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055840 Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA055840: AB_2682939" "unprognostic (1.36e-2)" "unprognostic (6.27e-4)" "unprognostic (6.30e-3)" "unprognostic (5.34e-2)" "unprognostic (8.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.15e-2)" "unprognostic (8.28e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-2)" "unprognostic (2.01e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-3)" 0.6 1.2 0.6 0.6 0.6 0.0 1.5 0.6 0.6 0.9 1.3 0.6 0.6 0.6 0.6 0.6 1.4 0.8 0.7 0.8 0.6 0.2 4.5 4.7 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.7 0.6 0.6 1.8 0.9 4.1 2.4 0.8 1.4 1.9 1.5 0.6 0.6 0.6 1.1 0.6 0.6 0.6 3.1 0.6 0.6 0.6 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.7 0.6 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.0 0.0 0.5 3.7 2.3 1.6 0.0 0.0 3.7 0.0 4.5 2.6 0.2 0.0 0.2 0.0 1.9 1.1 3.2 0.7 0.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.4 2.8 0.1 0.2 0.1 0.3 0.5 0.6 0.4 0.4 0.5 0.0 0.9 0.2 0.0 0.5 0.0 1.8 1.5 0.3 0.0 0.7 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.2 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.2 1.1 0.0 0.2 0.0 0.0 0.2 4.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 9.8 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 DCTN1 ENSG00000204843 "Dynactin subunit 1" Q14203 2 74361154-74392087 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009108, HPA034635, HPA071875" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No 220000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: " "unprognostic (1.14e-1)" "unprognostic (7.19e-2)" "unprognostic (1.33e-3)" "unprognostic (4.08e-2)" "unprognostic (1.20e-1)" "unprognostic (2.67e-1)" "unprognostic (4.61e-3)" "unprognostic (2.11e-2)" "unprognostic (2.79e-1)" "unprognostic (3.73e-3)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.34e-7)" "unprognostic (5.41e-2)" "unprognostic (3.11e-1)" "unprognostic (7.86e-3)" "unprognostic (1.12e-3)" 20.7 21.1 36.0 13.7 54.6 11.1 14.0 45.9 70.9 23.5 17.1 37.8 8.9 11.8 18.5 9.8 22.9 19.7 15.1 37.7 39.5 35.8 13.5 10.0 18.9 10.9 37.7 40.3 21.9 15.2 70.2 21.6 17.2 54.6 16.5 14.0 13.2 23.5 21.7 39.5 19.9 13.7 26.5 32.2 12.4 16.0 25.5 26.7 9.4 17.0 9.5 12.8 17.2 18.0 11.6 12.1 12.9 15.8 9.8 16.7 15.5 19.1 22.5 21.1 22.0 38.8 29.0 17.1 30.9 32.3 39.5 28.2 29.9 14.8 26.4 12.7 64.2 21.8 19.2 25.8 39.3 30.2 32.9 26.0 27.4 18.1 25.1 30.0 14.9 34.0 34.7 19.2 42.9 25.6 27.1 33.7 24.2 11.8 18.9 29.7 16.4 27.1 15.5 22.8 23.5 24.0 24.4 37.2 18.9 21.9 11.9 26.1 23.1 17.3 20.8 18.6 19.2 13.4 10.9 25.5 36.0 26.1 15.4 23.0 11.7 9.3 24.0 33.7 24.4 25.2 7.3 11.4 12.9 16.7 14.2 13.5 11.6 9.5 12.4 12.1 8.6 6.8 7.5 9.8 9.8 15.8 9.6 8.1 15.5 36.0 54.6 45.9 70.9 39.5 35.8 37.7 40.3 54.6 26.7 29.8 20.1 9.7 8.2 9.0 26.0 50.1 12.7 12.0 15.9 27.9 23.6 24.7 16.6 19.4 5.8 25.5 38.3 23.3 17.1 23.3 20.8 9.2 28.8 17.0 24.6 85.8 16.0 25.8 15.9 3.9 41.4 16.7 15.1 27.9 26.4 15.6 21.6 24.6 48.8 16.1 43.6 19.4 27.1 28.4 35.7 10.3 21.1 13.8 20.7 9.5 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.8" "Group enriched" "Detected in some" 32 "Sertoli cells: 750.3;Smooth muscle cells: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 6.4 0.7 12.4 0.7 18.2 0.6 3.2 4.5 9.7 5.7 1.9 3.6 0.4 1.5 6.4 7.6 2.5 3.1 7.1 11.0 12.4 10.1 2.6 0.6 21.6 1.7 15.8 6.8 2.0 2.0 2.5 0.3 61.8 8.7 3.6 1.0 0.7 1.3 4.4 7.9 1.3 1.3 7.3 6.2 0.4 1.5 1.2 8.9 0.1 3.4 1.8 1.1 3.0 1.6 1.1 3.3 4.6 2.9 1.9 3.5 1.1 0.5 1.8 0.0 2.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 1.0 0.6 1.7 0.5 0.0 0.1 0.7 0.0 0.0 0.0 1.4 2.0 0.4 2.1 1.3 0.0 2.6 3.7 0.0 0.0 0.0 0.0 0.6 0.0 2.6 2.1 1.5 0.0 0.7 1.9 2.0 1.3 0.7 1.0 2.2 1.2 2.5 0.0 1.3 2.2 1.0 0.6 0.0 0.3 0.1 0.9 1.1 0.0 1.8 0.6 1.2 1.4 1.3 3.9 2.0 1.6 3.1 2.2 4.6 1.9 0.7 3.5 2.9 1.3 0.7 2.3 2.6 3.3 1.1 2.5 2.3 0.0 1.9 0.3 0.9 2.0 1.1 12.4 18.2 4.5 9.7 12.4 10.1 15.8 6.8 8.7 8.9 0.0 0.3 0.0 0.5 3.1 0.4 3.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 14.7 0.0 0.0 0.0 0.2 2.0 0.3 0.0 0.0 0.6 1.6 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.5 750.3 198.1 0.0 0.2 2.0 0.2 0.0 0.0 0.7 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769763-121835079 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 111.8;Spermatogonia: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.5 10.8 9.9 25.1 12.6 16.6 21.9 14.7 16.8 14.4 11.8 8.8 16.9 11.0 14.7 19.4 13.1 15.9 11.5 10.4 10.1 10.1 10.6 9.0 15.0 20.6 12.5 14.5 19.8 22.7 13.9 20.7 12.1 12.4 16.2 15.6 10.9 14.4 30.2 11.4 14.2 14.0 14.6 11.4 19.3 11.2 40.1 12.5 16.2 11.4 9.5 23.0 16.7 14.1 18.9 7.6 8.9 10.4 8.6 10.0 4.9 14.0 3.8 18.8 21.1 3.0 4.6 22.1 6.7 4.1 7.6 9.2 12.9 6.8 28.4 9.4 3.8 11.7 10.8 11.5 5.4 11.4 5.5 9.3 18.8 7.5 10.6 7.8 23.3 5.7 2.9 10.4 5.2 11.7 3.9 5.7 12.2 11.2 10.6 8.4 7.1 15.2 16.5 15.8 8.4 6.9 15.1 8.9 9.0 4.4 6.3 10.0 8.1 6.5 4.6 11.6 6.4 4.1 18.3 4.8 7.2 8.7 3.5 8.7 25.7 16.3 48.3 6.9 10.7 6.5 2.5 5.2 8.9 6.3 9.9 9.0 18.9 8.3 7.6 7.6 17.5 10.0 6.3 2.1 8.6 10.4 7.2 8.7 4.9 9.9 12.6 14.7 16.8 10.1 10.1 12.5 14.5 12.4 12.5 6.0 15.9 17.1 15.3 16.8 14.7 7.7 15.3 62.9 27.3 10.4 25.5 23.4 3.3 8.8 2.8 9.0 5.9 0.0 11.3 6.9 13.9 12.8 8.1 5.6 9.1 12.7 6.9 6.2 10.0 5.3 14.4 10.5 13.5 17.2 8.9 11.8 10.6 9.1 12.7 5.8 27.3 12.9 11.7 111.8 63.7 18.1 11.8 13.3 12.6 14.8 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Cell line enhanced" "Detected in some" "A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" NA NA "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: AB_2685972" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 6.6 12.5 0.0 0.5 0.0 0.0 11.8 0.0 16.2 0.0 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 21.3 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 7.9 0.0 0.0 0.9 20.5 0.1 0.0 0.0 1.9 2.9 6.3 8.2 0.0 0.1 13.9 0.0 1.5 9.0 0.2 0.1 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 11.9 9.1 0.5 10.7 0.0 0.4 0.3 12.7 9.4 4.5 14.0 0.0 28.2 21.6 24.5 0.3 0.1 17.1 0.0 20.6 20.1 0.8 11.8 0.0 2.9 2.4 0.0 7.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 14.1 1.0 18.2 22.9 0.0 7.3 2.1 0.0 0.2 5.8 7.0 0.0 24.8 1.5 17.2 16.2 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.5 4.7 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 15.7 0.2 0.0 1.4 0.1 0.4 0.1 0.1 0.7 0.1 3.7 0.1 0.0 0.4 11.4 16.8 0.3 1.6 0.1 0.3 0.0 0.6 31.6 1.7 19.8 0.0 0.0 9.1 4.1 2.0 1.5 0.0 3.2 0.0 16.8 0.1 0.0 3.2 0.4 0.2 0.2 0.2 0.8 0.0 3.4 1.1 0.0 1.4 0.0 0.1 36.2 16.7 7.8 1.6 4.9 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 0.0 6.7 6.1 0.2 0.9 21.3 1.2 0.0 0.0 0.0 1.8 55.0 0.0 0.0 0.6 20.0 1.8 0.0 0.0 1.4 0.1 0.9 0.3 5.8 0.0 1.4 1.6 0.0 0.6 3.8 57.7 0.9 2.5 0.0 2.8 1.1 22.6 1.7 0.0 0.0 0.0 23.6 6.5 1.2 1.4 2.5 0.9 0.0 11.7 0.7 1.8 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Group enriched" "Detected in many" 4 "Early spermatids: 321.9;Late spermatids: 423.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.2 14.7 29.4 19.2 6.5 10.1 15.3 21.7 16.9 44.9 39.7 31.5 13.8 12.1 11.1 14.6 35.8 36.2 31.3 20.1 40.7 21.5 15.3 35.9 33.0 19.8 6.1 19.2 18.8 5.2 11.6 22.6 22.7 11.0 25.1 30.5 25.8 21.0 37.7 15.8 16.6 15.5 18.5 26.8 22.4 17.1 22.1 14.0 15.6 13.0 28.7 19.9 18.1 20.0 4.8 18.6 20.9 13.8 12.9 21.7 22.2 22.1 30.0 18.0 29.1 21.8 13.4 25.8 17.7 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 8.9 0.6 0.8 3.1 1.9 7.8 4.7 2.5 9.4 5.7 0.0 7.9 14.3 3.3 9.5 321.9 1.7 1.6 46.7 8.1 35.4 6.2 3.8 1.1 5.7 18.4 4.8 2.4 3.1 7.5 423.6 8.3 7.6 3.3 8.2 3.6 7.0 8.7 0.0 6.7 4.4 7.4 0.0 2.7 83.7 18.1 1.3 17.6 3.2 3.0 2.8 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Cell line enhanced" "Detected in some" "Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" NA NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 0.0 1.4 2.2 0.0 0.1 7.5 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 1.1 57.2 0.0 0.0 1.2 5.6 0.6 0.2 3.3 8.2 0.0 4.0 0.2 0.0 0.0 0.0 4.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010676 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027045, HPA076357" Supported Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA027045: AB_1854847, HPA076357: " "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favorable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favorable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 8.8 6.2 5.8 2.6 12.3 0.3 6.2 8.5 8.9 8.6 6.3 20.6 4.0 4.6 8.5 4.1 6.1 7.6 4.3 5.3 6.0 4.5 8.6 5.6 0.9 12.7 5.1 9.2 4.5 12.5 4.3 5.3 11.6 5.3 5.6 7.4 5.4 6.3 13.2 4.3 5.1 8.9 8.5 2.3 5.2 9.6 12.5 0.0 8.3 2.3 2.1 6.3 7.1 0.6 0.6 4.7 0.3 1.4 2.3 0.2 11.5 9.3 6.5 10.9 8.6 8.1 6.2 8.2 12.0 9.8 6.8 6.8 9.4 0.1 5.3 14.8 4.4 9.2 9.2 9.0 10.4 11.1 4.7 4.4 12.9 4.6 9.2 5.0 4.9 8.9 7.0 16.6 14.6 7.7 8.0 1.4 12.1 12.6 7.0 11.8 0.9 1.4 8.3 8.7 9.1 1.2 9.0 2.9 3.8 15.9 4.2 8.0 14.4 10.6 12.9 8.9 8.8 2.7 9.5 10.2 9.5 6.8 9.5 13.5 13.0 1.3 9.1 1.5 16.7 4.7 0.3 1.3 2.3 0.2 1.7 0.6 1.0 1.4 0.1 0.6 0.9 1.0 1.2 1.4 0.3 0.6 0.6 0.2 32.8 9.4 2.2 22.0 14.2 25.3 16.2 12.7 12.0 15.9 10.4 100.1 16.8 6.6 11.5 56.6 14.7 19.3 23.3 9.6 7.6 13.6 16.9 0.0 29.3 2.8 22.3 16.7 12.3 0.6 57.7 13.6 2.5 35.4 7.2 12.2 25.5 16.8 21.0 21.5 10.3 66.3 0.0 11.3 10.7 6.4 14.4 17.7 6.7 9.2 21.0 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295643-23302848 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 61.2;Early spermatids: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 4.2 7.6 14.5 8.2 22.5 5.5 6.8 27.3 22.9 6.5 5.8 17.5 8.4 9.7 8.2 16.6 4.3 6.5 5.4 4.7 12.4 12.6 9.3 6.9 5.1 13.6 27.0 20.7 11.8 7.1 11.7 14.3 4.4 20.8 9.3 9.6 7.4 6.3 10.4 13.6 16.9 8.8 5.8 21.6 11.0 7.8 11.5 25.9 5.9 13.8 4.9 12.3 5.2 7.0 3.0 1.1 1.6 4.7 0.9 1.7 1.0 0.8 2.2 2.7 1.9 5.2 2.3 1.3 0.9 1.6 1.5 1.3 1.2 4.2 8.0 0.6 1.1 1.6 5.6 1.6 0.8 1.8 2.9 1.6 1.4 4.2 2.8 1.4 1.6 3.3 1.9 3.3 0.9 4.6 2.5 0.7 4.4 1.3 7.3 1.2 1.9 1.5 2.6 0.6 2.6 2.0 2.4 1.8 5.1 0.8 1.8 3.3 0.9 1.3 1.1 0.8 1.4 1.4 0.6 1.2 1.8 1.0 3.1 0.6 30.7 3.2 3.7 1.4 2.9 1.1 0.5 1.3 0.5 1.5 3.9 1.7 3.0 0.5 0.7 1.1 2.3 1.7 1.0 1.6 0.9 4.7 1.0 1.0 1.0 14.5 22.5 27.3 22.9 12.4 12.6 27.0 20.7 20.8 25.9 3.0 3.7 10.8 7.8 4.9 61.2 7.7 2.5 2.7 4.5 19.2 35.3 6.1 5.0 1.8 92.4 6.0 10.7 0.0 2.9 1.6 3.9 5.5 3.5 6.4 6.2 30.2 8.1 8.6 7.8 50.4 25.3 8.2 10.1 1.0 6.4 22.9 2.8 4.8 24.4 5.9 38.7 12.9 2.8 24.7 9.1 8.0 4.3 10.1 8.3 7.8 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase, non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5;lymphoid tissue: 63.7" "Group enriched" "Detected in many" 5 "B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basal ganglia: 9.4;thalamus: 2.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6" "Cell line enhanced" "Detected in some" "HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2" "Region enriched" "Detected in single" 10 "basal ganglia: 5.5" "Region enriched" "Detected in all" 4 "basal ganglia: 10.9" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" NA NA Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 2.6 3.1 0.5 27.1 9.4 24.5 0.6 0.4 0.5 0.6 2.3 0.6 0.0 3.0 0.7 0.6 1.7 0.8 2.9 0.5 0.6 0.8 1.1 0.9 3.2 16.5 1.2 0.2 0.6 0.6 0.0 0.7 0.4 0.8 1.3 1.9 0.7 5.3 0.3 0.4 0.6 3.7 0.9 1.6 15.4 1.4 12.7 2.9 63.7 0.9 0.6 24.8 2.9 0.8 2.6 2.6 17.0 1.1 9.9 10.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 16.7 0.0 0.0 0.0 36.3 48.9 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.7 1.5 0.0 0.0 4.9 15.8 0.0 0.0 0.0 0.7 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 7.4 1.8 10.5 0.0 26.2 0.0 11.5 1.1 17.0 10.6 1.1 9.5 1.9 7.1 10.5 2.0 2.6 5.3 6.4 7.1 9.9 0.4 2.6 9.0 2.8 0.5 9.4 0.4 0.5 0.6 0.8 1.2 0.2 0.8 2.9 3.0 9.0 40.6 1.0 2.1 2.4 0.7 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.4 2.9 0.0 0.0 0.0 0.1 1.7 0.5 137.4 0.5 15.6 0.0 0.0 4.9 6.2 1.3 4.9 23.4 8.5 9.0 0.0 5.6 0.1 0.0 2.1 0.6 4.4 0.0 0.9 0.9 0.4 2.0 0.7 156.8 0.0 0.5 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603913-143609773 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 6.1 8.1 11.5 6.7 9.7 4.8 5.6 5.3 13.4 6.9 5.4 6.1 10.8 4.4 4.7 5.2 6.1 10.1 6.3 4.4 12.2 8.5 7.7 20.5 5.9 6.7 7.6 12.1 6.7 10.6 4.3 9.1 3.5 9.7 7.5 4.0 4.5 13.7 9.1 4.8 4.7 4.9 4.0 4.4 5.9 7.0 8.6 4.5 3.8 9.5 6.3 6.1 3.6 3.1 11.1 5.4 0.4 1.4 3.2 3.2 2.1 5.9 11.1 2.0 4.3 1.9 1.2 4.2 5.3 2.2 4.3 2.4 4.9 5.8 7.8 7.1 3.8 1.6 5.0 1.9 6.2 0.8 5.3 6.8 3.8 4.2 3.2 1.9 1.7 1.2 2.1 1.6 4.9 2.8 1.4 2.4 5.0 5.9 2.4 2.0 18.2 7.4 1.3 1.8 5.5 18.0 5.2 1.9 11.7 3.9 3.8 7.2 2.4 8.5 10.9 2.0 0.8 13.4 2.2 2.1 3.8 8.0 5.9 4.9 4.2 1.0 4.9 4.5 2.4 3.5 0.3 1.4 0.2 3.2 1.1 3.1 5.8 2.1 2.6 2.1 11.1 3.0 3.0 0.4 3.2 1.0 5.4 1.8 2.1 11.5 9.7 5.3 13.4 12.2 8.5 7.6 12.1 9.7 4.5 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 14.0 0.0 4.9 3.3 7.1 0.0 0.0 0.0 0.0 7.9 10.5 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Group enriched" "Detected in many" 6 "Early spermatids: 207.9;Late spermatids: 131.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.7" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.4 3.9 2.7 1.7 12.1 12.4 1.6 7.3 9.3 3.6 3.8 1.0 11.4 2.4 3.2 10.8 2.3 3.9 0.9 4.9 4.6 4.7 2.7 4.0 1.6 3.4 6.3 0.0 4.1 17.7 3.8 5.0 0.7 6.1 2.0 1.2 4.8 2.0 6.5 1.3 0.8 4.1 5.2 6.6 3.9 0.0 0.7 0.4 9.5 3.1 2.1 7.9 5.7 0.6 6.4 2.3 1.2 5.5 2.8 5.1 5.4 2.7 2.8 3.9 6.8 4.8 6.0 0.9 5.1 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 26.8 23.5 5.4 7.2 2.2 3.7 3.6 7.6 13.4 27.3 5.2 2.0 1.7 6.6 4.2 207.9 3.6 21.2 0.0 3.4 0.8 7.3 2.5 15.1 12.9 4.4 4.8 4.6 3.7 6.5 131.8 8.6 4.4 5.0 1.8 11.2 5.8 2.4 7.0 5.6 5.9 2.2 6.5 3.9 3.9 3.7 2.0 0.7 3.8 15.9 2.0 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.5 0.0 0.0 0.0 0.0 26.7 17.3 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 0.0 0.0 0.0 0.3 0.1 74.6 1.6 0.0 0.0 0.0 7.0 21.6 0.0 10.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 12.7 5.1 0.0 0.0 36.0 1.1 0.0 0.0 0.0 0.7 6.5 0.3 0.0 0.4 18.3 24.1 0.0 0.1 2.1 2.5 0.0 0.1 0.0 0.2 0.4 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599279 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3;testis: 94.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 101.5;Spermatocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 10.1;T-reg: 6.2" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" NA Yes "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.1 1.1 2.3 7.6 3.8 16.5 1.7 2.7 3.4 1.7 5.1 0.8 0.5 3.9 2.0 1.9 3.8 0.5 1.8 1.7 1.8 3.7 12.7 9.5 2.6 6.5 1.5 0.7 1.4 1.9 0.4 1.9 3.3 1.3 1.3 5.3 1.3 1.4 0.9 0.8 2.5 7.1 1.5 1.9 5.8 1.7 94.2 1.0 27.3 3.9 5.5 11.2 1.8 1.3 1.2 0.4 10.1 0.7 1.0 6.2 1.2 23.8 25.3 30.3 23.5 1.5 2.5 12.4 19.3 12.2 28.7 23.2 19.7 7.3 16.8 10.5 13.4 27.0 20.8 32.9 12.2 30.7 30.2 21.1 17.8 25.2 23.9 0.2 23.1 22.5 0.8 1.1 23.1 12.0 4.2 15.0 26.2 19.2 29.7 23.3 15.7 30.4 27.5 16.3 19.2 12.8 20.3 42.2 20.0 8.6 12.7 23.0 13.5 27.7 33.4 9.6 26.1 23.8 21.2 7.4 16.6 27.9 13.7 32.9 13.8 21.1 25.9 11.2 17.7 26.4 10.1 0.0 0.3 0.6 0.7 1.1 0.9 1.8 1.3 0.1 1.2 1.5 1.4 0.6 1.0 0.4 0.4 6.2 1.2 2.3 3.8 2.7 3.4 1.8 3.7 1.5 0.7 1.3 1.0 3.0 1.7 2.2 1.1 1.8 4.7 0.4 0.0 10.7 2.3 0.0 0.0 1.7 1.7 0.5 101.5 1.0 6.2 23.3 0.3 10.6 1.1 0.6 1.1 3.9 5.3 3.2 12.5 4.3 1.8 14.4 0.9 3.6 0.0 1.0 2.3 0.6 0.3 0.8 0.0 10.9 3.3 6.5 1.7 43.6 23.0 0.9 3.2 2.5 2.7 0.5 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 731.6;Late spermatids: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 9.0 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.2 9.6 4.2 4.3 5.6 5.4 4.8 3.5 42.8 10.1 1.2 8.8 4.8 80.4 3.1 9.9 3.3 4.0 42.9 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.6 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.6 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 29.8 20.4 15.7 43.3 22.2 30.3 70.0 38.2 54.9 33.0 45.4 31.4 191.4 79.6 29.5 731.6 22.4 31.6 116.8 23.1 95.8 33.4 41.8 31.3 35.9 24.4 35.0 37.2 20.9 9.2 294.5 71.4 15.0 5.0 17.2 32.3 24.6 24.5 32.3 70.7 74.6 34.6 25.8 21.4 52.6 55.1 17.6 83.0 35.5 42.3 22.7 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822698-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "blood: 57.9;lymphoid tissue: 128.9" "Cell type enriched" "Detected in some" 10 "T-cells: 74.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 57.9" "Group enriched" "Detected in many" 160 "granulocytes: 53.1;T-cells: 57.9" "Group enriched" "Detected in some" 23 "JURKAT: 16.4;MOLT-4: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" NA NA "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 2.6 0.3 0.2 8.2 0.2 1.8 1.3 0.2 0.3 0.8 1.0 0.1 0.1 0.9 0.7 0.3 0.9 0.8 1.9 0.7 0.2 0.2 1.1 1.0 4.0 17.8 0.2 0.2 0.5 0.5 0.0 0.4 0.3 0.3 1.1 1.0 0.1 1.9 0.3 0.4 1.0 5.5 0.2 0.3 9.0 1.6 0.5 0.1 128.9 1.1 1.0 9.8 2.8 1.1 0.1 0.1 53.1 0.1 0.3 57.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 1.1 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.1 0.0 10.5 0.0 21.2 0.1 42.1 21.6 0.0 0.0 57.9 14.2 0.6 0.3 0.1 0.1 17.9 22.9 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 5.6 0.9 0.1 7.4 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 2.3 0.6 0.2 0.0 0.0 1.8 0.0 1.4 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 6.9 0.1 74.0 0.0 0.0 TUBB "M40, MGC16435, OK/SW-cl.56, Tubb5" ENSG00000196230 "Tubulin beta class I" P07437 6 30720201-30725426 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.7" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 1893.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005417, CAB012406, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes 510000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (1.01e-1)" "unprognostic (2.33e-1)" "unprognostic (2.17e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (2.18e-3)" "unprognostic (1.27e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.62e-8)" "unprognostic (8.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" 51.6 27.7 30.0 31.8 33.2 78.8 30.0 30.9 57.2 43.3 37.0 24.3 18.7 10.8 58.5 39.7 39.9 41.0 29.6 33.1 23.7 48.2 31.4 74.1 32.7 62.1 27.8 24.0 81.5 27.0 15.3 16.3 41.1 39.9 32.2 34.2 30.6 27.9 24.3 29.6 37.6 24.3 37.6 27.4 47.7 29.1 19.7 14.4 198.7 26.9 36.8 91.5 39.7 34.3 15.4 17.5 8.6 15.4 12.3 18.2 19.8 42.4 15.7 61.3 26.6 17.4 30.0 0.5 0.0 0.0 0.0 0.0 29.9 16.2 21.2 26.3 19.6 16.4 14.7 49.5 44.5 0.0 11.9 31.3 0.5 0.0 17.2 8.3 57.8 28.5 22.3 10.4 0.0 0.5 13.5 21.6 46.9 16.7 0.0 27.0 30.7 41.8 0.2 0.0 13.5 18.5 0.0 0.6 12.5 35.8 24.2 10.7 35.9 23.1 10.2 0.4 39.9 26.7 5.3 13.3 64.5 28.7 0.0 0.2 19.8 38.1 49.2 12.7 57.5 81.6 4.9 7.7 8.6 15.5 12.2 18.2 15.4 12.1 17.6 6.2 10.0 12.3 12.2 4.3 12.3 15.4 17.5 14.2 19.8 30.0 33.2 30.9 57.2 23.7 48.2 27.8 24.0 39.9 14.4 122.1 48.4 184.6 261.7 511.8 64.2 96.8 186.0 50.9 100.1 162.3 37.3 493.5 263.6 1083.5 6.9 247.2 97.2 700.8 929.9 1893.7 657.3 117.4 203.1 240.5 829.2 103.3 156.9 268.2 310.8 15.4 372.8 361.3 305.4 1224.5 123.1 172.7 843.8 91.2 223.1 178.3 51.0 116.4 444.0 46.2 42.8 376.4 184.3 200.5 178.2 168.9 TUBB1 dJ543J19.4 ENSG00000101162 "Tubulin beta 1 class VI" Q9H4B7 20 59019254-59026654 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 58.6;lymphoid tissue: 28.2" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 11.5;Erythroid cells: 23.3;Late spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "basophil: 8.7;neutrophil: 6.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 8.7" "Cell line enriched" "Detected in some" 19 "HEL: 25.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004286, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 480000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (3.76e-1)" "unprognostic (2.69e-1)" "unprognostic (6.10e-4)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (2.02e-1)" "unprognostic (5.86e-2)" "unprognostic (7.51e-4)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (6.80e-5)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "unprognostic (1.00e-1)" 0.6 0.3 0.2 0.4 0.6 12.2 0.2 0.7 0.7 0.2 0.2 0.1 0.0 0.2 0.2 0.9 0.2 0.5 0.6 10.8 0.2 0.2 0.2 1.0 8.3 0.4 0.2 0.4 0.8 0.4 0.0 0.7 3.2 0.6 0.3 0.0 0.5 0.2 0.6 0.6 0.2 0.5 0.0 0.6 28.2 0.3 1.8 0.0 0.0 0.5 0.3 0.2 0.4 1.8 0.1 0.6 8.7 0.5 0.0 0.1 58.6 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.0 0.6 1.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.2 0.0 0.3 0.3 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.3 8.7 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 6.5 0.0 0.0 0.6 0.1 58.6 0.2 0.6 0.7 0.7 0.2 0.2 0.2 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 23.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.6 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153669-3157526 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 158.3" "Cell type enhanced" "Detected in all" 7 "Horizontal cells: 487.8;Suprabasal keratinocytes: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.0;monocytes: 2.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 49.5;CACO-2: 50.0;SuSa: 77.3;WM-115: 55.3" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favorable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (1.61e-4)" 19.6 9.1 59.4 8.7 46.9 26.8 7.9 46.5 158.3 5.4 8.7 9.1 1.2 11.1 6.7 13.5 17.2 4.8 10.9 6.1 56.5 76.0 7.7 16.9 4.1 5.4 58.4 43.3 2.6 14.3 1.6 6.9 11.0 78.6 6.1 4.5 4.6 5.8 8.0 7.3 24.7 13.8 17.7 24.3 2.3 17.6 2.9 5.4 0.1 1.9 10.4 4.7 5.4 5.8 6.0 0.9 0.7 2.6 0.6 5.5 1.8 10.6 9.0 49.5 11.1 6.3 7.0 2.9 23.7 8.9 16.2 23.6 50.0 3.6 5.3 14.6 22.4 16.1 5.1 17.5 5.3 5.6 25.6 11.6 1.8 2.6 15.1 6.5 0.2 1.8 7.3 6.3 17.0 1.1 5.9 7.5 2.2 6.3 1.8 14.5 4.7 2.8 0.5 42.4 3.1 11.6 2.4 4.6 4.0 5.5 5.4 12.4 11.3 5.9 1.8 33.9 77.3 3.8 0.3 14.9 11.0 12.0 23.7 12.7 0.7 0.8 3.6 4.0 1.4 55.3 0.0 1.9 0.0 4.0 2.6 4.4 6.0 3.9 5.5 0.9 1.2 2.1 3.7 0.7 0.6 2.0 0.3 5.3 1.8 59.4 46.9 46.5 89.2 56.5 76.0 58.4 43.3 78.6 5.4 14.9 16.2 11.3 50.6 276.6 98.5 16.7 48.4 24.1 15.9 12.2 15.7 2.1 184.1 43.1 50.4 30.8 111.0 70.0 155.6 48.0 118.0 26.1 34.6 48.9 44.2 487.8 70.0 11.1 6.5 18.3 19.2 38.9 123.2 125.4 69.8 243.3 112.9 105.2 14.5 26.4 58.8 6.5 107.2 21.2 12.6 322.2 5.1 10.7 23.3 53.3 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3224261-3231730 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 125.4" "Group enriched" "Detected in many" 6 "Distal tubular cells: 351.5;Horizontal cells: 406.8;Muller glia cells: 726.9" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "AF22: 73.9;CACO-2: 54.3;NTERA-2: 36.2;RPMI-8226: 37.2;SCLC-21H: 110.9;SH-SY5Y: 53.8;SuSa: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 3.8 5.9 53.6 5.9 63.1 1.5 4.4 23.2 125.4 4.7 4.6 22.6 0.0 2.8 4.0 29.7 2.5 2.0 3.6 2.1 34.3 48.6 6.6 1.4 1.6 6.0 56.7 18.6 1.5 2.9 1.4 4.8 3.9 36.1 2.1 3.1 2.3 3.6 4.3 4.5 3.0 4.7 5.5 80.5 1.8 3.3 1.7 16.2 0.0 1.6 0.0 4.6 2.1 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 73.9 22.3 0.0 0.0 0.0 0.4 0.9 2.7 6.0 54.3 0.2 0.0 0.7 0.5 0.0 0.0 28.9 0.0 1.6 0.0 13.2 0.0 0.0 4.2 0.2 0.0 0.8 0.4 0.0 0.3 0.0 0.9 0.0 0.0 0.8 0.1 0.7 0.0 0.1 0.0 36.2 0.0 2.3 0.0 3.5 37.2 0.3 0.0 110.9 53.8 0.0 0.2 0.3 35.3 0.4 0.0 0.0 0.0 12.6 0.6 0.0 7.3 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 53.6 63.1 23.2 39.2 34.3 48.6 56.7 18.6 36.1 16.2 0.0 0.0 1.5 2.5 7.7 30.9 33.1 10.2 0.0 0.0 7.0 15.7 0.1 351.5 10.8 3.0 6.0 0.2 0.0 3.0 0.4 24.0 2.8 0.0 0.8 2.5 406.8 64.0 1.3 0.0 4.1 0.3 0.0 87.7 6.4 0.5 726.9 19.6 0.0 0.0 1.4 34.7 0.0 27.8 1.2 6.8 2.4 0.7 0.0 0.4 0.7 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.1" "Cell type enhanced" "Detected in some" 20 "Ductal cells: 22.7;Exocrine glandular cells: 18.4;Late spermatids: 9.5;Pancreatic endocrine cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.2" "Lineage enriched" "Detected in single" 7 "B-cells: 5.2" "Cell line enhanced" "Detected in many" "A549: 66.2;SCLC-21H: 67.5;SH-SY5Y: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 250000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.1 19.4 23.9 8.9 23.3 3.2 1.2 24.1 85.1 2.4 4.1 7.8 0.0 3.6 7.9 1.1 2.2 1.0 7.3 1.8 25.0 66.5 1.1 1.1 1.6 5.7 44.5 15.9 1.1 2.5 1.0 9.9 2.2 60.9 1.6 2.8 5.5 1.9 1.3 1.0 4.1 4.8 9.3 12.9 1.1 2.5 11.2 3.3 0.0 1.0 1.7 4.4 5.3 0.6 5.2 0.7 0.2 0.3 0.0 0.2 0.2 4.6 66.2 24.7 28.1 2.9 28.5 1.0 28.4 4.8 17.1 7.8 9.0 8.6 14.0 14.8 21.4 12.0 17.5 23.8 4.2 4.3 3.4 2.3 0.1 5.6 58.7 0.9 0.0 11.0 16.3 1.2 26.2 2.3 22.3 14.1 0.9 1.4 0.5 19.5 44.1 0.1 4.7 43.3 1.7 36.4 0.0 8.7 1.5 21.3 1.3 67.5 68.2 39.9 0.7 19.4 4.7 2.2 0.2 17.6 23.5 25.3 31.4 28.7 0.2 2.8 5.3 24.3 1.8 41.5 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 23.9 23.3 24.1 51.0 25.0 66.5 44.5 15.9 60.9 3.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 22.7 5.3 0.0 0.0 0.0 18.4 0.3 0.0 0.0 0.0 0.0 0.2 4.8 4.7 0.0 0.0 9.5 0.3 0.0 0.0 0.0 0.0 0.2 44.3 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 TUBB4A "beta-5, DYT4, TUBB4" ENSG00000104833 "Tubulin beta 4A class IVa" P04350 19 6494319-6502848 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 62.6;brain: 197.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 9.5;Melanocytes: 13.5;Muller glia cells: 31.5" "Group enriched" "Detected in many" 9 "glioma: 50.1;melanoma: 83.2;testis cancer: 49.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "B-cells: 5.3;T-cells: 6.5" "Cell line enhanced" "Detected in many" "AN3-CA: 36.3;HAP1: 20.8;HEL: 30.5;PC-3: 15.1;REH: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010768, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 360000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (8.42e-7)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (8.08e-2)" "unprognostic (6.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.58e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" 2.3 62.6 41.3 2.9 52.4 2.2 2.3 115.3 197.8 2.2 2.9 115.2 0.0 2.7 2.3 2.3 2.5 2.3 2.4 2.3 56.8 36.9 2.8 2.2 2.3 2.6 73.7 34.5 2.6 2.8 2.1 0.2 2.5 72.0 2.2 2.5 2.7 2.7 2.3 3.9 4.6 3.2 2.5 73.2 4.8 2.2 31.3 43.0 0.0 2.1 0.0 2.4 2.3 0.1 5.3 0.1 0.2 0.0 0.4 6.5 1.6 0.0 10.7 0.0 36.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 10.6 0.0 1.3 0.3 20.8 0.0 0.2 0.0 3.4 30.5 0.7 0.3 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.3 0.0 6.0 2.9 0.2 0.0 1.0 6.1 1.3 2.7 0.0 15.1 15.0 0.0 7.1 3.9 0.0 0.1 12.1 0.1 0.1 10.6 1.0 0.3 0.7 0.0 0.0 4.5 0.0 0.1 0.8 0.5 4.1 0.4 0.0 0.2 0.0 0.0 0.0 6.3 0.0 4.6 5.3 1.0 6.5 0.0 1.6 2.2 4.7 0.2 0.4 0.0 0.1 0.0 1.6 41.3 52.4 115.3 79.7 56.8 36.9 73.7 34.5 72.0 43.0 0.0 0.0 0.5 0.5 1.6 2.6 8.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 1.6 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.3 9.5 0.0 0.6 0.0 5.6 4.9 0.0 13.5 0.0 0.0 31.5 0.2 0.0 0.4 1.6 1.7 6.5 1.7 1.4 1.1 1.4 0.1 0.0 0.0 0.1 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241213-137243707 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 207.7" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 31.1 22.1 33.0 22.1 32.7 87.5 24.4 22.3 67.2 23.0 44.0 35.9 25.2 33.4 22.7 52.7 65.7 122.5 32.1 66.4 35.2 55.5 46.6 49.7 28.4 21.0 33.8 46.6 33.7 33.0 13.4 25.3 31.9 48.4 29.8 27.3 40.9 41.8 31.8 37.1 55.9 38.9 28.4 21.5 21.0 30.5 207.7 12.2 61.1 40.1 56.7 40.1 21.8 25.7 17.2 18.3 37.0 14.6 11.2 21.7 14.4 59.3 89.0 38.1 27.4 19.2 20.3 53.1 55.8 47.0 77.2 53.4 94.0 73.1 36.4 42.7 54.1 75.3 113.0 47.1 89.8 29.4 25.9 39.8 26.4 70.9 73.8 12.1 31.0 29.4 13.0 25.5 58.9 16.2 19.2 55.1 26.1 36.8 21.0 63.6 163.2 28.1 42.3 40.2 105.3 155.3 35.8 72.7 33.7 58.0 55.6 26.7 28.7 73.9 42.6 14.8 22.6 61.3 33.8 42.7 55.2 61.5 62.5 73.3 8.1 22.5 40.2 45.0 24.3 47.8 37.0 14.1 20.5 21.4 14.6 20.6 17.2 16.7 18.2 17.5 14.1 10.7 14.3 28.6 11.2 14.6 18.3 21.7 14.4 33.0 32.7 22.3 67.2 35.2 55.5 33.8 46.6 48.4 12.2 205.4 139.7 150.7 842.9 289.7 457.2 82.3 132.5 1026.5 175.1 136.1 282.7 235.6 187.3 348.8 1754.5 152.3 547.1 490.6 391.5 458.3 161.8 365.4 188.9 114.3 228.8 230.4 375.8 129.5 67.2 2132.3 235.3 111.2 131.6 359.7 292.5 271.2 343.5 375.2 143.9 259.6 647.3 109.9 245.2 1761.9 564.6 260.1 268.5 97.8 359.3 575.4 TUBB6 "HsT1601, MGC4083" ENSG00000176014 "Tubulin beta 6 class V" Q9BUF5 18 12307669-12344320 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.7" "Group enriched" "Detected in many" 5 "B-cells: 14.8;dendritic cells: 46.7" "Cell line enhanced" "Detected in many" "TIME: 94.1" "Region enriched" "Detected in single" 10 "olfactory region: 24.5" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes 150000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.40e-2)" "unprognostic (8.28e-3)" "unprognostic (1.22e-2)" "unprognostic (5.20e-3)" "unprognostic (8.42e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-2)" "unprognostic (4.95e-2)" "unprognostic (4.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (5.83e-3)" "unprognostic (1.99e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (9.69e-4)" 63.0 7.2 4.2 24.0 7.6 7.9 46.6 3.2 3.9 47.4 38.7 5.6 14.7 8.9 62.8 36.3 83.3 28.6 35.9 39.5 5.1 5.5 13.6 8.2 23.6 28.4 6.1 2.5 42.3 18.0 0.9 7.3 27.3 11.9 34.7 8.3 15.6 14.9 27.1 17.4 21.6 16.2 84.4 7.1 15.3 22.0 15.0 4.7 4.2 14.5 47.4 32.8 62.1 26.1 14.8 46.7 0.5 5.8 0.3 0.1 3.5 23.2 16.0 17.1 8.8 17.6 24.5 12.2 72.5 48.3 56.0 52.3 12.0 7.6 0.1 33.7 48.2 17.2 11.3 9.2 71.6 43.0 0.2 5.0 3.7 18.4 8.0 17.8 0.3 6.9 25.5 16.6 47.9 25.9 17.5 40.6 1.4 17.4 0.3 47.6 23.6 0.1 17.6 9.1 0.4 7.7 0.1 29.7 0.2 10.9 0.6 2.3 3.1 42.1 4.1 12.4 18.1 8.9 23.3 94.1 71.8 59.0 66.2 67.2 1.3 0.4 0.4 55.2 5.2 25.5 0.5 5.8 0.0 0.1 2.2 0.1 11.7 0.0 0.0 7.6 14.8 0.0 0.1 0.1 0.3 2.0 46.7 0.0 3.5 4.2 7.6 3.2 3.9 5.1 5.5 6.1 2.5 11.9 4.7 77.4 9.3 11.5 34.7 61.8 1.0 45.2 10.2 13.4 23.9 7.0 0.0 49.8 1.7 133.5 171.4 65.5 0.0 0.0 92.9 423.0 106.7 14.4 43.9 0.4 67.7 0.0 0.0 79.2 11.7 98.9 65.0 55.0 32.1 111.0 0.1 0.0 147.5 0.0 85.9 0.6 1.6 25.8 106.6 5.0 4.3 58.5 18.5 2.5 0.2 49.6 TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46892-74163 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.2;parathyroid gland: 2.3;testis: 2.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 9.6;Spermatocytes: 13.5;Spermatogonia: 8.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;MCF7: 5.4;NTERA-2: 1.9" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.0 0.0 0.5 0.0 1.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.5 0.3 0.1 0.5 1.0 0.1 2.2 0.3 0.2 0.5 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.4 0.1 0.0 1.9 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.7 0.2 0.4 1.0 0.4 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.2 0.1 2.2 0.5 0.2 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 13.5 8.7 0.0 0.0 0.0 0.0 0.7 TUBB8P12 ENSG00000173213 "Tubulin beta 8 pseudogene 12" A6NNZ2 18 47390-49557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.7" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;neutrophil: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;Hep G2: 2.2;MCF7: 1.7;T-47d: 2.3;U-266/70: 1.8;U-266/84: 1.9" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.29e-1)" "unprognostic (6.73e-2)" "unprognostic (1.76e-1)" "unprognostic (6.91e-2)" "unprognostic (1.92e-1)" "unprognostic (4.36e-2)" "unprognostic (1.29e-1)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (7.42e-4)" "unprognostic (3.96e-2)" "unprognostic (5.98e-2)" "unprognostic (4.88e-2)" "unprognostic (3.21e-2)" "unprognostic (1.78e-1)" 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 1.3 0.1 0.3 0.5 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.3 7.4 0.1 0.1 0.6 0.1 0.4 0.0 1.1 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 2.2 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.7 0.2 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 1.8 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.6 11.2 13.4 19.4 10.7 14.1 17.4 11.9 18.3 14.3 15.6 12.2 13.6 31.9 12.4 15.3 13.3 11.0 18.2 12.1 14.4 17.5 18.2 14.5 15.0 11.7 12.5 21.4 17.8 16.2 25.4 13.0 19.2 16.1 12.2 20.6 16.3 21.7 11.7 11.9 19.7 16.5 24.9 10.2 9.6 32.1 13.6 25.1 10.0 8.7 19.4 20.3 13.0 14.1 14.5 16.3 15.6 25.6 12.6 15.2 14.6 11.2 11.1 23.3 24.7 38.5 5.9 10.8 10.7 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 0.0 14.4 9.1 14.5 15.5 10.2 3.6 12.7 4.0 4.5 1.8 0.0 9.7 6.6 8.9 41.6 11.1 6.0 0.0 8.6 8.9 10.8 11.4 6.9 5.8 8.0 3.2 12.7 5.5 8.9 26.2 7.5 8.0 15.1 8.2 9.2 10.1 8.2 3.5 7.4 5.0 9.0 12.9 18.6 11.4 10.4 18.1 9.3 10.0 11.7 11.9